Skip over navigation
Banner
Directory
Directory Search
Jobs
Job Search Post a Job
Patient
Patient Resources Drug Development
History
Genealogy
Toons & Teasers
Industry
 Directory
 Toons & Teasers
Quick Links
 Directory
 Job Search
 Toons & Teasers
 Advertising
 
Facilities
 

EquipNet Auction: Cyteir & Moment Biosciences Late Model Lab Instruments - June 14-15

Sign Up for University of Washington Online Master of Pharmaceutical Bioengineering

Our newest cartoon revisits "Milestones in Polio"


Utah Life Science Industry Directory

EquipNet Auction: Former Cyteir Therapeutics and Moment Biosciences Late Model Lab Instruments - June 14-15,  @ 9 am EST

Banner Advertising

Please note that we have a new site: LifeScienceHistory.com, "Where history is made daily" under development and delayed by COVID-19, to be launched in 2023 replacing UtahLifeScience.com. Regrettably, we are working with reduced staffing and the current industry directory is no longer being maintained, but will be replaced with a new and improved directory upon the launch of the new site. We apologize for the inconvenience.

Xenocor Inc


Xenocor Inc
630 Komas Dr. Suite 200
Salt Lake City, UT 84108
 
 
Year Established:  1997
Main Contact: Ashok C. Khandkar, PhD, CEO
 
Other Contacts:  John Langell, MD, PhD, MPH, MBA, FACS, President
 
Company Description
Xenocor is an emerging company that aims to revolutionize minimally invasive laparoscopic surgery by bringing its Xenoscope™, a novel low cost, single-use, HD imaging multi-purpose scopes to the market. This scope promises to disrupt the high capital cost laparoscopy systems market and greatly expand the delivery of high-quality surgical care to the hundreds of millions of patients world-wide.


Main Industry Directory

 
Email thie page to a friend. Email This Page
to a Friend
Print this page. Print This
Page
© 1997 - 2023 Info.Resource, Inc. All rights reserved.
Privacy Policy . Cookie Policy . Terms of Use . About . Advertising

UtahLifeScience.com is owned and published by Info.Resource, Inc.